An Observational Study of Patients With Chronic Kidney Disease

Target PharmaSolutions

Status: Withdrawn

Conditions: End Stage Kidney Disease; Kidney Disease, Chronic

Treatments: Other: Observational

Study type: Observational

Funder types: Industry

Identifiers

NCT05774392

TARGET-KIDNEY

Details and patient eligibility

About

TARGET-KIDNEY is an observational research study to conduct a comprehensive review of outcomes for patients with chronic kidney disease (CKD) and end-stage renal disease (ESKD).

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Disease Cohort

Inclusion Criteria:

• Adult* patients at the time of enrollment with a diagnosis of CKD/ESKD by ICD-10 code in the EHR interface

Exclusion Criteria:

• Death
• Manual removal (sponsor or site request)
• No EHR interface encounter > 3 years

Engaged Cohort

Inclusion Criteria:

• Adult * patients diagnosed and managed for CKD/ESKD invited to participate
• Ability to provide written informed consent

Exclusion Criteria:

• Patient expressed desire to withdraw consent to complete PROs
• Failure to complete PROs within 24 weeks of initial invitation
• Greater than 24 months lapse of survey completion after baseline surveys completed
• Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort

Trial design

0 participants in 2 patient groups

Disease Cohort

Treatment:

Other: Observational

Engaged Cohort

Treatment:

Other: Observational